Multiple Sclerosis

Australia


We are committed to becoming a long-term partner to the Multiple Sclerosis community by working to deliver scientific advancements that will have a significant impact on the needs of people living with Multiple Sclerosis.

Driven by Science

For over a decade, Genzyme and our parent company Sanofi have each been working to develop novel treatments for relapsing/remitting MS. We have integrated these two programs within Genzyme to establish ourselves as a leader in MS. Since that time, we have established a portfolio of MS therapies including two registered MS treatments.

In addition, we continue to conduct cutting-edge research in MS, focusing on developing medicines to repair the damaged immune system and treat progressive MS.

What is Multiple Sclerosis?

Multiple Sclerosis is a chronic disease of the central nervous system that affects each person differently, with symptoms ranging from numbness in the limbs to paralysis and loss of vision. MS is caused when the body’s immune system attacks the central nervous system, damaging the myelin sheath – the protective layer covering the nerves that carry signals between the brain and spinal cord and the rest of the body.

More about Multiple Sclerosis

Finding effective treatments for a complex disease like Multiple Sclerosis is no easy task, so we have ensured that our MS research is spearheaded by top experts, employing some of the most advanced and creative scientific problem-solving skills in the industry.

We recognise that truly personalised medicine involves developing relationships with patients and caregivers, health care providers, and disease organisations and foundations. We have built our MS therapy group on the same core principle that has guided our company from the beginning: the importance of deeply understanding the experiences, challenges, and triumphs of those living with a disease. We aim to foster close connections with patient organisations to best understand the needs of patients and their families, and to deliver services that have a positive impact.

Our Inspiration
Last Updated: 12/12/2014
Contact Us

Genzyme Australia
Building D, 12-24 Talavera Road
Macquarie Park, NSW, 2113
Australia
T: +61 2 8666 2000
F: +61 2 8666 3000

Mailing Address:
Genzyme Australia
Locked Bag 2227
North Ryde BC, NSW, 1670
Australia

Send Email
This is Genzyme

Discover more about Genzyme's purpose, legacy, and innovation in our corporate brochure.

Careers

Explore opportunities at a company that's as committed to our employees as we are to our patients.

Funding

Genzyme provides funding, sponsorships and charitable donations to support diverse organisations and initiatives that we believe can make a meaningful difference around the world.

infoBox